Peregrine, Affitech team up

Peregrine Pharmaceuticals and Affitech will collaborate on the production of human antibodies for Peregrine's vascular targeting agent and anti-angiogenesis programs. Tustin, CA-based Peregrine will provide targets, while Affitech of Oslo, Norway, will apply its human antibody libraries and discovery and screening technologies to generate a panel of human antibodies against the targets. The firms did not release financial details of the relationship.

By AuntMinnie.com staff writers
June 18, 2003

Related Reading

Peregrine regains Nasdaq compliance, June 12, 2003

Peregrine, Schering team up, January 7, 2003

Peregrine begins Nasdaq grace period, August 22, 2002

Peregrine closes institutional investment deal, August 14, 2002

Peregrine lands $5.75 million investment, November 19, 2001

Copyright © 2003 AuntMinnie.com

Page 1 of 603
Next Page